“Comparison of the Efficacy of Generation 1 and 2 Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer Patients With EGFR Positive Mutations”. Indian Journal of Forensic Medicine & Toxicology 15, no. 3 (May 17, 2021): 4316–4324. Accessed May 7, 2026. https://medicopublication.com/index.php/ijfmt/article/view/15970.